Company Profiles

driven by the PitchBook Platform

Aggamin Biologics

Description

Developer of biologic drugs for diseases including preeclampsia. The company is engaged in developing and commercializing therapies for a variety of unmet diseases.

2010

Founded

PRIVATE

Status

Early Stage VC

Latest Deal Type

1

Investors

Description

Developer of biologic drugs for diseases including preeclampsia. The company is engaged in developing and commercializing therapies for a variety of unmet diseases.

Ownership Status

Privately Held (backing)

Financing Status

Venture Capital-Backed

Primary Industry

Drug Discovery

Other Industries

Biotechnology
Pharmaceuticals

Primary Office

3960 Broadway New York, NY 10032United States +1 (212) 568-4614
    Request a free trial to the PitchBook Platform
    You're viewing a free company profile from the PitchBook Platform. To explore Aggamin Biologics's full profile, request a free trial.

    Aggamin Biologics Valuation and Funding

    Request access
    Deal TypeDateAmountRaised to DatePost-ValStatusStage

    Aggamin Biologics Investors (1)

    Request access
    Investor NameInvestor TypeHoldingInvestor SinceParticipating RoundsBoard
    Seat
    Contact
    Info
    Broadview VenturesVenture CapitalMinority000 0000000 0000
    Broadview Ventures Venture Capital

    Aggamin Biologics Executive Team (2)

    NameTitleBoard
    Seat
    Contact
    Info
    Paul Kussie Ph.DFounder & Chief Executive Officer
    Adlene Tan Ph.DSenior Scientist
    Paul Kussie Ph.D Founder & Chief Executive Officer
    Adlene Tan Ph.D Senior Scientist

    Aggamin Biologics Board Members (1)

    NameRepresentingRoleSinceContact
    Info
    Frederick Jones MDBroadview VenturesDirector000 0000
    Frederick Jones MD Director Broadview Ventures
    Request full access to PitchBook